Nonpharmacological Interventions for Protection of Myocardial Ischemia-reperfusion Injury among Patient with ST Elevation Myocardial Infarction: A Brief Review

被引:0
作者
Jangra, Mandeep Kumar [1 ]
Mirza, Mehroz Ahmed [3 ]
Goyal, Manu [2 ]
机构
[1] Maharishi Markandeshwar Inst Physiotherapy & Rehab, Dept Cardiopulm Physiotherapy, Ambala, Haryana, India
[2] Maharishi Markandeshwar Inst Physiotherapy & Rehab, Ambala 133207, Haryana, India
[3] Maharishi Markandeshwar Inst Med Sci & Res, Dept Cardiol, Ambala, Haryana, India
关键词
Acute myocardial infarction; cardioprotection; primary percutaneous coronary intervention; reperfusion injury; PERCUTANEOUS CORONARY INTERVENTION; ADJUNCTIVE THERAPY; SIZE; HYPOTHERMIA; SAFETY;
D O I
10.4103/jpcs.jpcs_2_24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction:Numerous nonpharmacological interventions are being investigated for cardioprotective effects among individuals with acute myocardial infarction (MI) who underwent revascularization. However, results of these trials are contradictory. This review aimed to explore the emerging nonpharmacological interventions to prevent myocardial reperfusion injury (RI).Materials and Methods:This review followed Introduction, Methods, Results, Discussion pattern for nonsystematic reviews. Article published form 2015 to November 2023 were retrieved from PubMed, Science direct, and Scopus. Population, Intervention, Comparator, Outcomes, Study design format was used to assess the eligibility of articles where population was ST elevated MI; Intervention was any nonpharmacological interventions such as ischemic postconditioning, therapeutic hypothermia, low level laser therapy (LLLT), remote ischemic conditioning (RIC), and therapeutic hyperoxemia; Comparator can be placebo/sham or control groups, Outcomes were infarct size and cardiac biomarkers and study design can be randomized clinical trials, pre-post experimental studies, etc.Results:15,889 articles were identified and after duplicate removal and assessing eligibility criteria, 27 articles were included in this review. Out of 27, 7 studies used ischemic post conditioning where only 3 studies revealed improvements in ejection fraction and reduction in cardiac biomarkers; 12 studies employed RIC in which only 2 studies showed improvements in ejection fraction whereas 5 showed reduction in peak cardiac biomarkers, 7 experimental studies used therapeutic hypothermia in which only 1 study showed reduction in infract size postintervention, and one study used LLLT where reduction in cardiac biomarkers was seen postintervention.Conclusion:Ischemic postconditioning and RIC showed significant results on myocardial RI whereas therapeutic hypothermia revealed nonsignificant results in most of the trials and failed to prove its efficacy in preventing Myocardial RI. However, a new intervention LLLT proved to be significantly effective in preventing myocardial RI in one human clinical trial.
引用
收藏
页码:137 / 144
页数:8
相关论文
共 50 条
  • [21] Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
    Fernandez Rico, Carlota
    Konate, Karidia
    Josse, Emilie
    Nargeot, Joel
    Barrere-Lemaire, Stephanie
    Boisguerin, Prisca
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [22] Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction
    Hortmann, M.
    Robinson, S.
    Mohr, M.
    Haenel, D.
    Mauler, M.
    Stallmann, D.
    Reinoehl, J.
    Duerschmied, D.
    Peter, K.
    Bode, C.
    Ahrens, I.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 485 - 491
  • [23] Ischemia-reperfusion injury is still a big hurdle to overcome for treatment of acute myocardial infarction
    Inoue, Teruo
    JOURNAL OF CARDIOLOGY, 2016, 67 (3-4) : 305 - 306
  • [24] B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction
    Arakawa, Kentaro
    Himeno, Hideo
    Kirigaya, Jin
    Otomo, Fumie
    Matsushita, Kensuke
    Nakahashi, Hidefumi
    Shimizu, Satoru
    Nitta, Manabu
    Takamizawa, Tetsu
    Yano, Hideto
    Endo, Mitsuaki
    Kanna, Masahiko
    Kimura, Kazuo
    Umemura, Satoshi
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (01) : 62 - 70
  • [25] Pharmacological protection of reperfusion injury in ST-segment elevation myocardial infarction. Gone with the wind?
    Tonet, Elisabetta
    Bernucci, Davide
    Morciano, Giampaolo
    Campo, Gianluca
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2018, 14 (01): : 5 - 8
  • [26] The role of neutrophils in myocardial ischemia-reperfusion injury
    Jordan, JE
    Zhao, ZQ
    Vinten-Johansen, J
    CARDIOVASCULAR RESEARCH, 1999, 43 (04) : 860 - 878
  • [27] Trimetazidine ameliorates myocardial ischemia-reperfusion injury
    He, Chuanbo
    Cao, Shujun
    Tong, Zichuan
    Wang, Wenbin
    Zhang, Yin
    Guo, Changlei
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 31 (04) : 1691 - 1696
  • [28] Clarithromycin attenuates myocardial ischemia-reperfusion injury
    Nakajima, Takuya
    Hishikari, Keiichi
    Ogawa, Masahito
    Watanabe, Ryo
    Suzuki, Jun-ichi
    Nagashima, Ayako
    Masumura, Mayumi
    Takayama, Kiyoshi
    Hirata, Yasunobu
    Nagai, Ryozo
    Isobe, Mitsuaki
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (09) : 881 - 893
  • [29] Reperfusion options in ST-elevation myocardial infarction patients with expected delays
    Larson D.M.
    Henry T.D.
    Current Cardiology Reports, 2008, 10 (5) : 415 - 423
  • [30] Aborted myocardial infarction in patients with ST-segment elevation myocardial infarction treated with mechanical reperfusion
    Konarski, Lukasz
    Debinski, Marcin
    Kolarczyk-Haczyk, Aleksandra
    Jelonek, Michal
    Kondys, Marek
    Buszman, Pawel
    KARDIOLOGIA POLSKA, 2021, 79 (01) : 39 - 45